Search PubMed⌕ Search

Biomedical subjects

R Varma

Publications and source records attributed to R Varma.

At least 109 records · Page 6Linked to original sources

Long-term lithium treatment and the kidney. Interim report on fifty patients.

This is a report on the first part of our study of the effects of long-term lithium treatment on the kidney. Creatinine clearance, maximum urinary osmolality and 24 hour urine volume have been tested in 50 affectively ill patients who have been on long-term lithium for more than one year. These findings have been compared with norms and with values of the same tests from screening prior to lithium, available for most of our patients. No evidence was found for any reduction of glomerular filtration during lithium treatment. Low clearance values found in several patients could be accounted for by their age and their pre-lithium values. Urinary concentration defect appeared frequent but the extent of the impairment is difficult to assess because of the uncertainty about the norms applicable to this group of patients. The concentration defect appeared reversible, at least in part. Polyuria above 3 litres/24 hours was found in 10% of patients. An attempt is made to draw practical conclusions from the preliminary findings.

Adult↗

Glycosaminoglycan levels in sera of patients with mental disorders.

A nonspecific increase in serum glycosaminoglycans was observed in mental conditions associated with psychosis, brain trauma and mania but not in depression. Significant elevations also occurred in alcoholics and epileptics. The role of glycosaminoglycans in relation to the blood-brain barrier and mental illness has been discussed.

Adult↗

Simple gas-chromatographic measurement of valproic acid in psychiatric patients: effect on levels of other simultaneously administered anticonvulsants.

A simple, rapid and precise gas-chromatographic procedure which involves one-step extraction and on-column methylation for routine clinical monitoring of plasma valproic acid levels is described. Six other commonly, simultaneously administered anticonvulsants can also be determined by substituting methylene chloride for chloroform for extraction and changing the column temperature. Also, described is the effect of valproic acid on blood levels of other simultaneously administered anticonvulsants.

Adult↗

Serum and mucopolysaccharide (glycosaminoglycans) levels in psychiatric patients.

Serum acid glycosaminoglycans (GAG) levels were measured in 50 normals and 177 samples from different types of psychiatric patients. Mean levels were significantly higher in paranoid type schizophrenia, organic brain syndrome associated psychosis and manic type manic-depressive psychosis. The levels returned to slightly above the normal range upon partial remission in paranoid schizophrenics. In catatonic and hebephrenic schizophrenias the values were in the upper part of normal range. The levels were either in upper normal range or slightly higher in non-psychotic organic brain syndrome. In depressed type manic depressive psychosis levels were either lower than normal or in the lower part of normal range.

Adolescent↗

Therapeutic monitoring of anticonvulsant drugs in psychiatric patients: rapid, simultaneous gas-chromatographic determination of six commonly used anticonvulsants without interference from other drugs.

A simple, sensitive and precise gas-chromatographic method for simultaneous extraction, derivatization and determination of methsuximide, ethosuximide, diphenylhydantoin, carbamazepine, phenobarbital and primidone in the presence of other drugs has been described. The method is especially useful for drug monitoring in patients on multiple anticonvulsant therapy while also on combination therapy with psychotropic drugs. It overcomes the analytical interferences between mephenytoin and phenobarbital; methsuximide and primidone; kemadrin and primidone; cholesterol and primidone; prolixin, haldol and other drugs; encountered in other methods using underivatized, trimethylsilylated or methylated drugs. As little as 0.5 microgram/ml of a drug can be determined and if needed the method can be scaled down to 0.3 ml plasma. The method yielded recoveries of 97-103% with standard deviations of 0.7-1.8. For a constant check of the precision, an internal quality control using daily analysis of a sample from a frozen plasma pool supplemented with known concentrations of the anticonvulsants was used. The method is suitable for use in routine clinical laboratory.

Anticonvulsants↗

Improved assay of urinary total 17-hydroxycorticosteroids.

A reliable method for the quantitative determination of "total 17-hydroxycorticosteroids has been described. Urine is subjected to reduction with sodium borohydride which reduces the 17-hydroxy-20-keto-21-deoxy steroids to 17,20-dihydroxy-21-deoxy steroids and 17-ketosteroids to C19 17-hydroxysteroids. Subsequent oxidation with sodium bismuthate oxidizes all the C21 17-hydroxysteroids to the corresponding 17-ketosteroids, which are extracted with CHCl3 : Bu-OH using ammonium sulfate as the salting out agent and finally the color reaction is performed with m-dinitrobenzene and the absorbance is measured. The 17-ketosteroids originally present in the urine do not interfere, since NaBH4 reduces them to C19 17-hydroxysteroids which cannot be oxidized with sodium bismuthate and do not respond to the color reaction with m-dinitrobenzene.

17-Hydroxycorticosteroids↗

A simple procedure for combined gas chromatographic analysis of neutral sugars, hexosamines and alditols. Determination of degree of polymerization of oligo- and polysaccharides and chain weights of glycosaminoglycans.

A reliable and reproducible method that allows the combined, simultaneous gas chromatographic (GC) determination of neutral sugars, hexosamines, alditols, identification and quantitation of the reducing aldose end-group in oligo and polysaccharides and glycosaminoglycans has been described. It involves the following steps: release of the reducing end-group from its protein linkage in glycosaminoglycans and reduction of this reducing end-group into alditol, release of the components of the reduced polymer by resin-catalysed hydrolysis, nitrous acid deamination of the resin-bound hexosamines in this hydrolysate into anhydroaldoses and a combined derivatization and GC determination of the neutral sugars as aldononitrile acetates, anhydroaldoses as peracetylated oximes and alditols as alditol acetates. Application of the method to determination of degree of polymerization of oligo-and polysaccharides and chain weights of proteoglycans has been described. This method has several advantages over the previous methods.

Animals↗

On arabinose as a component of brain hyaluronate. Confirmation by chromatographic, enzymatic and chemical ionization-mass spectrometric analyses.

The controversy about the presence of the pentose arabinose in brain hyaluronate was reinvestigated using modern analytical tehcnics. The purified bovine brain hyaluronate contained the neutral sugars: arabinose, 0.18%; glucose, 0.05%; and fucose, 0.22%. The confirmation of the presence of arabinose was obtained by paper and thin layer chromatography of the neutral sugars in deionized hyaluronate hydrolysate. Gas-liquid chromatography of the aldononitrile peracetate of the pentose isolated by preparative paper chromatography gave a single distinct peak, corresponding to standard arabinose on three columns packed with three different phases. Chemical ionization data and mass spectrum of the aldononitrile peracetate derivative agreed with those of the authentic arabinonitrile tetracetate. Analysis of the isolated pentose with the help of the enzymes L-arabinose isomerase and L-ribulose kinase, which are specific for their substrates, further established its identity as L-arabinose.

Animals↗

Simultaneous determination of neutral sugars and hexosamines in glycoproteins and acid mucopolysaccharides (glycosaminoglycans) by gas-liquid chromatography.

A reliable and reproducible method for the simultaneous determination of neutral sugars and hexosamines in glycoproteins and acid mucopolysaccharides has been described. It involves the following steps: the release of neutral sugars and hexosamines from biopolymers by resin-catalysed hydrolysis, the nitrous acid deamination of resin-bound hexosamines in this hydrolysate to aldoses, and the determination of these newly formed anhydroaldoses together with the pre-existing neutral sugars as aldononitrile acetates by gas chromatography. Applications of this method to analyses of glycoprotein from urine of schizophrenic patients, bovine thyroglobulin, human brain glycoprotein, chondroitin sulfates from bovine vitreous humor, and veal brain, and human umbilical cord hyaluronic acid are given.

Animals↗

Human umbilical cord hyaluronate. Neutral sugar content and carbohydrate-protein linkage studies.

Paper chromatography of neutral sugars and gas chromatography of their aldononitrile acetates indicated the presence of fucose, arabinose and a small amount of glucose in purified human umbilical cord hyaluronate. The molar ratios of serine, threonine and aspartic acid to neutral sugars were not unity, suggesting the non-involvement of the neutral sugars and the amino acids in a carbohydrate-protein linkage. The same was indicated by an increase in the percentage of the aforementioned amino acids and by the absence of sugar alditols in umbilical cord hyaluronate reduced eith NaBH4 -PdCl2, after alkali treatment. This reduction caused a decrease in the intrinsic viscosity and molecular wieght to about one-half and an appreciable decrease in the specific rota tion of hyaluronate, suggesting a separation of the two antiparallel chains o the double helical hyaluronate. The umbilical cord hyluronate containe contained bound silicon and it is possible that this bound silicon may cross-link the two chains at interspersed intervals through the uronic acid moiety and/or through neutral sugars.

Amino Acids↗